Full-Time
Updated on 7/3/2025
Global healthcare company providing medicines access
No salary listed
Senior
Remote in USA
Remote
Telecommuting permitted from anywhere within the United States.
Viatris provides a wide range of healthcare solutions by combining generic and brand-name medications to meet global health needs. The company operates a global supply chain that allows it to deliver high-quality medicines to patients in various locations, ensuring access to essential treatments. Viatris's extensive portfolio includes medications for both acute and chronic conditions, addressing health challenges throughout different stages of life. Unlike many competitors, Viatris focuses on bridging the gap between generics and brands, which enables them to reach a broader audience. The company's goal is to empower individuals worldwide to lead healthier lives by providing access to necessary medications.
Company Size
10,001+
Company Stage
IPO
Headquarters
Canonsburg, Pennsylvania
Founded
1961
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Life Insurance
401(k) Retirement Plan
401(k) Company Match
Wellness Program
Paid Holidays
Biocon's acquisition of Viatris for $3.3 billion marks a potential turning point for the company, which has seen muted growth. Despite revenue growth, concerns about debt, equity dilution, and valuation persist. Biocon's business now includes biosimilars, contract research, and generics. The company plans to raise ₹4,500 crore through a Qualified Institutional Placement to reduce its ₹17,756 crore debt. A potential merger with Biocon Biologics Ltd could unlock further value.
PITTSBURGH, May 7, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that on May 5, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The dividend is payable on June 16, 2025, to shareholders of record as of the close of business on May 23, 2025.About ViatrisViatris Inc. (Nasdaq: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris
PITTSBURGH, March 28, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report first quarter 2025 financial results on Thursday, May 8, 2025. Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally
PITTSBURGH, March 5, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, will present at the Barclays 27th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, March 11, 2025. The company's fireside chat will begin at 2 p.m. ET.A live webcast of the event at can be found at investor.viatris.com. An archived version of the presentation will be available following the live event and can be accessed at the same location for a limited time.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally
PITTSBURGH, Feb. 27, 2025 /PRNewswire/ --